Ballentine Partners, LLC Bio Rad Laboratories, Inc. Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q3 2024
A detailed history of Ballentine Partners, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 679 shares of BIO stock, worth $221,068. This represents 0.0% of its overall portfolio holdings.
Number of Shares
679Holding current value
$221,068% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$621 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$505 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$424 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$354 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$232 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.02B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...